Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
195.65 EUR | +0.98% |
|
+1.32% | +3.68% |
Capitalization | 19.04B 20.71B 18.32B 16.03B 29.81B 1,801B 32.79B 210B 79.62B 759B 77.63B 76.06B 3,071B | P/E ratio 2025 * |
61.5x | P/E ratio 2026 * | 46x |
---|---|---|---|---|---|
Enterprise value | 21.21B 23.07B 20.41B 17.86B 33.21B 2,006B 36.53B 234B 88.7B 846B 86.49B 84.74B 3,422B | EV / Sales 2025 * |
7x | EV / Sales 2026 * | 6.19x |
Free-Float |
30.28% | Yield 2025 * |
0.37% | Yield 2026 * | 0.47% |
Last Transcript: Sartorius Stedim Biotech
1 day | +0.98% | ||
1 week | +1.32% | ||
Current month | -1.68% | ||
1 month | -7.27% | ||
3 months | +0.80% | ||
6 months | +5.87% | ||
Current year | +3.68% |







Manager | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 49 | 2023-03-27 |
Chief Tech/Sci/R&D Officer | 60 | 2011-09-07 | |
Petra Kirchhoff
IRC | Investor Relations Contact | 56 | - |
Director | Title | Age | Since |
---|---|---|---|
Chairman | 59 | 2007-06-28 | |
Henri Riey
BRD | Director/Board Member | 63 | 2007-06-28 |
Director/Board Member | 63 | 2015-04-06 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
0.42% | 33 M€ | -5.28% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.98% | +1.32% | -28.20% | -40.44% | 20.71B | ||
-2.45% | -7.61% | +9.72% | +7.86% | 220B | ||
+0.80% | -1.51% | +11.37% | -11.70% | 119B | ||
+1.43% | -1.55% | -4.53% | -12.64% | 64.89B | ||
+0.80% | +1.37% | +8.33% | +70.47% | 50.04B | ||
+1.08% | +0.32% | -9.22% | +37.76% | 40.32B | ||
+3.23% | -9.19% | -45.81% | -32.04% | 27.62B | ||
+1.10% | +2.83% | -3.01% | +56.87% | 27.42B | ||
+1.88% | -2.63% | -1.49% | +1.98% | 22.27B | ||
+2.23% | +1.83% | -12.14% | -7.74% | 21.89B | ||
Average | +1.11% | -1.48% | -7.50% | +7.04% | 61.43B | |
Weighted average by Cap. | -0.06% | -3.32% | +1.65% | +6.95% |
2025 * | 2026 * | |
---|---|---|
Net sales | 3.03B 3.3B 2.92B 2.55B 4.74B 287B 5.22B 33.43B 12.67B 121B 12.36B 12.11B 489B | 3.39B 3.69B 3.26B 2.85B 5.31B 321B 5.84B 37.4B 14.18B 135B 13.82B 13.54B 547B |
Net income | 310M 337M 298M 261M 485M 29.31B 534M 3.42B 1.3B 12.36B 1.26B 1.24B 50B | 421M 458M 405M 354M 659M 39.78B 724M 4.64B 1.76B 16.78B 1.72B 1.68B 67.85B |
Net Debt | 2.17B 2.36B 2.09B 1.83B 3.4B 206B 3.74B 23.97B 9.09B 86.68B 8.86B 8.68B 351B | 1.96B 2.13B 1.88B 1.65B 3.07B 185B 3.37B 21.61B 8.19B 78.12B 7.99B 7.82B 316B |
Date | Price | Change | Volume |
---|---|---|---|
25-03-14 | 195.65 € | +0.98% | 52,902 |
25-03-13 | 193.75 € | -0.54% | 51,953 |
25-03-12 | 194.80 € | +4.73% | 86,363 |
25-03-11 | 186.00 € | -1.20% | 85,383 |
25-03-10 | 188.25 € | -2.51% | 63,316 |
Real-time Euronext Paris, March 14, 2025 at 12:35 pm EDT
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DIM Stock